Literature DB >> 28413002

Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.

Shaokun Zhang1, Zhenshan Lv1, Songyuan Zhang1, Lidi Liu1, Qiao Li1, Weiquan Gong1, Hui Sha1, Hong Wu2.   

Abstract

Peripheral blood was collected from a clinically diagnosed 72-year old male patient with later onset Alzheimer's disease. Peripheral blood mononuclear cells (PBMCs) were reprogrammed with the Yamanaka KMOS reprogramming factors using the Sendai-virus reprogramming system. The transgene-free iPSC line showed pluripotency verified by immunofluorescent staining for pluripotency markers, and the iPSC line was able to differentiate into the 3 germ layers in vivo. The iPSC line also showed normal karyotype. This in vitro cellular model will be useful for studying the pathological mechanism of Alzheimer's disease.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28413002     DOI: 10.1016/j.scr.2016.12.024

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  3 in total

Review 1.  Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.

Authors:  Fernanda Majolo; Daniel Rodrigo Marinowic; Denise Cantarelli Machado; Jaderson Costa Da Costa
Journal:  J Biomed Sci       Date:  2019-02-06       Impact factor: 8.410

2.  Current status and future prospects of stem cell therapy in Alzheimer's disease.

Authors:  Fu-Qiang Zhang; Jin-Lan Jiang; Jing-Tian Zhang; Han Niu; Xue-Qi Fu; Lin-Lin Zeng
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

3.  Discovering the Potential of Dental Pulp Stem Cells for Corneal Endothelial Cell Production: A Proof of Concept.

Authors:  Begoña M Bosch; Enrique Salero; Raquel Núñez-Toldrà; Alfonso L Sabater; F J Gil; Roman A Perez
Journal:  Front Bioeng Biotechnol       Date:  2021-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.